NHS Lanarkshire Revenue and Competitors
Estimated Revenue & Valuation
- NHS Lanarkshire's estimated annual revenue is currently $1.2B per year.
- NHS Lanarkshire's estimated revenue per employee is $378,000
Employee Data
- NHS Lanarkshire has 3062 Employees.
- NHS Lanarkshire grew their employee count by 9% last year.
NHS Lanarkshire's People
Name | Title | Email/Phone |
---|---|---|
1 | Student Orthotist | Reveal Email/Phone |
2 | Healthcare Assistant | Reveal Email/Phone |
3 | Senior Infrastructure Engineer | Reveal Email/Phone |
NHS Lanarkshire Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.6M | 52 | 0% | N/A | N/A |
#2 | $37M | 137 | 5% | N/A | N/A |
#3 | $16.5M | 68 | -16% | N/A | N/A |
#4 | $42.5M | 143 | 4% | N/A | N/A |
#5 | $48.4M | 163 | 6% | N/A | N/A |
#6 | $25.1M | 93 | 0% | N/A | N/A |
#7 | $8.6M | 40 | 11% | N/A | N/A |
#8 | $234.2M | 694 | 5% | N/A | N/A |
#9 | $85.5M | 288 | 10% | N/A | N/A |
#10 | $24.8M | 92 | 7% | N/A | N/A |
What Is NHS Lanarkshire?
NHS Lanarkshire website
keywords:N/AN/A
Total Funding
3062
Number of Employees
$1.2B
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NHS Lanarkshire News
2022-04-20 - NHS Lanarkshire hits breast cancer screening target
NHS Lanarkshire has hit its target on breast cancer screening following the pandemic. The health board saw 71.7 per cent of available women...
2022-04-06 - Essential visiting only to remain across NHS Lanarkshire sites
across NHS Lanarkshire's acute inpatient wards. However, the health board say this is something that is being monitored and reviewed daily. It...
2022-03-30 - NHS Lanarkshire takes over responsibility of vaccinations ...
For routine vaccinations such as pneumococcal and shingles, people will be contacted directly by NHS Lanarkshire when they become eligible.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1157.4M | 3062 | 4% | N/A |
#2 | $300M | 3064 | 9% | N/A |
#3 | $1165.8M | 3084 | 9% | N/A |
#4 | $300M | 3109 | N/A | N/A |
#5 | $300M | 3144 | N/A | N/A |